CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.10
+8.75%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 1.70x
- P/S forward
- 5.00x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -2.33x
- Price / sales
- 292.79x
- Price / cash flow
- -3.62x
Enterprise value
- Enterprise value
- $70.4M
- EV / sales
- 357.12x
- EV / EBITDA
- -2.53x
- EV / EBIT
- -3.47x
- Market cap
- $57.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026